Follow
David Wiercigroch
David Wiercigroch
Psychiatry Resident, University of Toronto
Verified email at mail.utoronto.ca - Homepage
Title
Cited by
Cited by
Year
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
D Wiercigroch, H Sheikh, J Hulme
Substance Abuse Treatment, Prevention, and Policy 15, 1-10, 2020
472020
Pharmacological investigations of a yohimbine–impulsivity interaction in rats
MK Mahoney, JH Barnes, D Wiercigroch, MC Olmstead
Behavioural Pharmacology 27 (7), 585-595, 2016
172016
Understanding current practice of opioid use disorder management in emergency departments across Canada: a cross-sectional study
P Hoyeck, D Wiercigroch, C Clarke, R Moineddin, H Sheikh, J Hulme
Canadian Journal of Emergency Medicine 22 (4), 494-498, 2020
82020
The design and evaluation of a master of science program in anatomical sciences at Queen's University Canada
K Kolomitro, LW MacKenzie, D Wiercigroch, L Godden
Anatomical Sciences Education 11 (6), 613-622, 2018
72018
A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
D Wiercigroch, P Hoyeck, H Sheikh, J Hulme
BMC Emergency Medicine 21, 1-9, 2021
62021
Regional anesthesia in Canadian emergency departments: emergency physician practices, perspectives, and barriers to use
D Wiercigroch, M Ben-Yakov, D Porplycia, SM Friedman
Canadian Journal of Emergency Medicine 22 (4), 499-503, 2020
62020
P138: management of opioid withdrawal: a qualitative examination of current practices and barriers to prescribing buprenorphine in a Canadian emergency department
D Wiercigroch, P Hoyeck, H Sheikh, J Hulme
Canadian Journal of Emergency Medicine 21 (S1), S114-S114, 2019
62019
Re-thinking conferences in medicine: opportunities and challenges of virtual delivery
H Pang, D Wiercigroch, A Sriharan
celebrates the 25th issue of 7 (1), 51, 2020
32020
Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists
P Grenier, D Wiercigroch, MC Olmstead, CM Cahill
Behavioural pharmacology 29 (2 and 3), 241-254, 2018
32018
Responding to Canada’s opioid crisis
M Driedger, D Wiercigroch, MD MUN, A Franklyn, J Milden, A Sharp, ...
Ottawa (ON): Canadian Federation of Medical Students (CFMS), 2018
12018
Canadian Conference on Medical Education 2021 Abstracts
H MacNeill, K Nemethy, J Liang, R Neferu, T Ahmad, M Arget, K Butler, ...
2021
P006: Time for a national conversation: Practices and perspectives on HIV testing in Canadian emergency departments
D Wiercigroch, E Xie, J Hulme, M Landes
Canadian Journal of Emergency Medicine 22 (S1), S66-S66, 2020
2020
P005: Regional anesthesia in Canadian emergency departments: Emergency physician practices and impressions
D Wiercigroch, S Friedman, D Porplycia, M Ben-Yakov
Canadian Journal of Emergency Medicine 22 (S1), S66-S66, 2020
2020
119 Opioid Use Disorder Management in Canadian Emergency Departments: A Cross-Sectional Survey
P Hoyeck, D Wiercigroch, C Clarke, H Sheikh, J Hulme
Annals of Emergency Medicine 74 (4), S48-S49, 2019
2019
MP01: Retention and treatment outcomes for patients with substance use disorders treated in a rapid access to addiction medicine clinic
D Wiercigroch, H Sheikh, J Hulme
Canadian Journal of Emergency Medicine 21 (S1), S42-S42, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–15